HTLV-I transmission from mother to child

被引:55
作者
Fujino, T
Nagata, Y
机构
[1] Kagoshima Univ, Sch Hlth Sci, Fac Med, Kagoshima 8908506, Japan
[2] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima 8908506, Japan
关键词
mother-to-child transmission; human T-lymphotropic virus type I (HTLV-I); breast milk; cord blood; placenta; apoptosis;
D O I
10.1016/S0165-0378(00)00054-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human T-lymphotropic virus type I (HTLV-I), a causative agent of adult T-cell leukemia, (ATL) is transmitted from mother to child. ATL cells originate From the CD3 subset of peripheral T cells. The main route of mother-to-child transmission is postnatal breast-feeding. Refraining from breast-feeding or limiting the duration of breast-feeding can reduce the risk of mother-to-child transmission. Other than postnatal breast-feeding, there seem to be two routes of HTLV-I transmission from mother to child. One is intrauterine transmission, and the other is via saliva. Intrauterine transmission is rare, although proviral DNA is detected in cord blood samples. HTLV-I proviruses in the cord blood may be defective. HTLV-I proviral DNA and antibodies against HTLV-I are also detected in saliva. However, no report has been published so far which showed direct evidence of HTLV-I transmission via saliva. The placenta can be infected by HTLV-I, but infection does not reach the fetus, possibly apoptosis of placental villous cells because it is induced by HTLV-I infection. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:197 / 206
页数:10
相关论文
共 53 条
[1]   Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers [J].
Achiron, A ;
PinhasHamiel, O ;
Barak, Y ;
Doll, L ;
Offen, D ;
Djaldetti, R ;
Frankel, G ;
Shohat, B .
ARCHIVES OF VIROLOGY, 1996, 141 (01) :147-153
[2]   EFFECT OF FREEZE-THAWING BREAST-MILK ON VERTICAL HTLV-I TRANSMISSION FROM SEROPOSITIVE MOTHERS TO CHILDREN [J].
ANDO, Y ;
KAKIMOTO, K ;
TANIGAWA, T ;
FURUKI, K ;
SAITO, K ;
NAKANO, S ;
HASHIMOTO, H ;
MORIYAMA, I ;
ICHIJO, M ;
TOYAMA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (05) :405-407
[3]  
ANDO Y, 1987, JPN J CANCER RES, V78, P322
[4]  
ARCHIBALD D, 1987, Viral Immunology, V1, P241, DOI 10.1089/vim.1987.1.241
[5]   RETROSPECTIVE STUDY OF HIV, HEPATITIS-B, AND HTLV-I INFECTION AT A LONDON ANTENATAL CLINIC [J].
BANATVALA, JE ;
CHRYSTIE, IL ;
PALMER, SJ ;
KENNEY, A .
LANCET, 1990, 335 (8693) :859-860
[6]   HTLV-I/II INFECTION IN PREGNANT-WOMEN IN PARIS [J].
COURTOIS, F ;
BARIN, F ;
LARSEN, M ;
BROSSARD, Y ;
MASSELIN, A ;
ENGELMAN, P .
LANCET, 1990, 335 (8697) :1103-1103
[7]  
Fratazzi C, 1997, J IMMUNOL, V158, P4320
[8]   Apoptosis in placentas from human T-lymphotropic virus type I-seropositive pregnant women: A possible defense mechanism against transmission from mother to fetus [J].
Fujino, T ;
Iwamoto, I ;
Otsuka, H ;
Ikeda, T ;
Takesako, S ;
Nagata, Y .
OBSTETRICS AND GYNECOLOGY, 1999, 94 (02) :279-283
[9]   HTLV-I TRANSMISSION FROM MOTHER TO FETUS VIA PLACENTA [J].
FUJINO, T ;
FUJIYOSHI, T ;
YASHIKI, S ;
SONODA, S ;
OTSUKA, H ;
NAGATA, Y .
LANCET, 1992, 340 (8828) :1157-1157
[10]   The seroprevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan [J].
Goto, K ;
Sato, K ;
Kurita, M ;
Masuhara, N ;
Iijima, Y ;
Saeki, K ;
Ohno, S .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (03) :219-221